IDEAYA Biosciences (IDYA) Long-Term Investments (2019 - 2026)

IDEAYA Biosciences has reported Long-Term Investments for 8 years, with the latest figure at $301.7 million in Q1 2026.

• Quarterly Long-Term Investments fell 15.88% year-over-year to $301.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $301.7 million (down 15.88% YoY) and the FY2025 annual result came in at $410.3 million, up 1.1% from the prior year.
• Long-Term Investments fell to $301.7 million in Q1 2026 per IDYA's latest filing, from $410.3 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $410.3 million in Q4 2025 and troughed at $7.7 million in Q3 2022.
• A 5-year average of $192.1 million and a median of $242.6 million in 2024 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2022 and 2024: Long-Term Investments slumped 93.66% in 2022, then soared 1966.75% in 2024.
• Over 5 years, Long-Term Investments stood at $8.3 million in 2022, then jumped by 1192.44% to $107.5 million in 2023, then soared by 277.55% to $405.8 million in 2024, then rose by 1.1% to $410.3 million in 2025, then dropped by 26.46% to $301.7 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $301.7 million, $410.3 million, and $350.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.